StockWatch
·
Medical/Dental Instruments
Quarterly ResultAug 6, 2026, 05:28 PM

iRhythm Q2 Revenue $224.2M, Net Loss $(0.4)M; YTD Loss $(14.3)M

AI Summary

iRhythm Holdings, Inc. reported strong financial improvements for the second quarter and first half of 2026. Quarterly revenue increased by 20.1% to $224.2 million, while the net loss narrowed substantially to $(0.4) million from $(14.2) million in the prior year. For the six months ended June 30, 2026, the company's net loss also decreased significantly to $(14.3) million, compared to $(44.9) million in the same period last year, driven by robust revenue growth and improved gross profit.

Key Highlights

  • Q2 2026 Revenue: $224.2 million, up 20.1% from $186.7 million YoY.
  • Q2 2026 Net Loss: $(0.4) million, a significant reduction from $(14.2) million YoY.
  • YTD 2026 Revenue: $423.6 million, up 22.6% from $345.4 million YoY.
  • YTD 2026 Net Loss: $(14.3) million, down from $(44.9) million YoY.
  • Q2 2026 Gross Profit: $163.2 million, up 22.8% from $132.9 million YoY.
  • Net cash provided by operating activities YTD: $24.9 million, up from $19.8 million.
  • Cash and cash equivalents: $246.7 million as of June 30, 2026.
  • Litigation settlements expense: $13.95 million in Q2 2026.